NCT01868412

Brief Summary

In recent years, salve prepared from Norway spruce (Picea abies) resin and refined honey from manuka myrtle (Leptospermum scoparium), has successfully been used in medical context to treat both acute and chronic surgical wounds. The objective of this prospective, randomized and controlled clinical trial is to investigate healing rate and healing time of surgical wounds in patients, who have undergone peripheral vascular surgery, and whose complicated wounds are candidate for topical treatment with the resin or honey. In addition, factors contributing with delayed wound healing, antimicrobial properties, safety and cost-effectiveness of the resin salve and medical honey will be analyzed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2013

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

May 8, 2013

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 4, 2013

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
Last Updated

January 18, 2016

Status Verified

January 1, 2016

Enrollment Period

2.7 years

First QC Date

May 8, 2013

Last Update Submit

January 15, 2016

Conditions

Keywords

Wound healingWound infectionResin salveMedical honey

Outcome Measures

Primary Outcomes (1)

  • Wound Healing

    Healing rate of acute or chronic surgical wound within 6 months after vascular surgery (%).

    6 months

Secondary Outcomes (1)

  • Contributors for Wound Healing

    6 months

Other Outcomes (1)

  • Other Pre-specified Outcome Measure

    6 months

Study Arms (2)

Resin & honey

EXPERIMENTAL

Abilar 10% resin salve

Device: Abilar 10% resin salve

Resin vs. honey

ACTIVE COMPARATOR

Activon Tube 25 g

Device: Activon Tube 25 g

Interventions

The resin salve may be spread directly onto the wound, after which the area is covered with a bandage suitable for local wound care. The bandage prohibits salve from moving away from the wound area. If the skin condition is more widespread or contains cavities or fistulae, the salve may be spread as a film with a thickness of at least 1 mm onto a gauze or gauze ribbon that is then used to fill the cavity or fistulae channel. Bandages are changed every 1-3 days, depending on the degree of infection and amount of wound secretion.

Resin & honey

Wound care with the medical honey is carried out in the same manner than the resin salve treatment: honey may be spread directly onto the wound and the wound area is covered with a bandage suitable for local wound care. Similarly, if the skin condition is more widespread or wound contains cavities or fistulae, the medical honey may be spread as a film with a thickness of at least 1 mm onto a gauze or gauze ribbon that is then used to fill the cavity or fistulae channel. Bandages are changed every 1-3 days, depending on the severity of infection and amount of wound secretion.

Resin vs. honey

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Infected of non-infected acute or chronic wound after vascular surgery.
  • Need for topical wound care.
  • Need for wound healing follow-up at the surgical outpatient department.

You may not qualify if:

  • Life expectancy less than 6 months.
  • Advanced malignant disease.
  • Need for extensive surgical wound revision or skin transplantation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kuopio University Hospital

Kuopio, Kuopio, 70200, Finland

Location

Kuopio University Hospital

Kuopio, Kuopio, FI-70029, Finland

Location

MeSH Terms

Conditions

Wound Infection

Condition Hierarchy (Ancestors)

Infections

Study Officials

  • Tommi Auvinen, MD

    Kuopio University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 8, 2013

First Posted

June 4, 2013

Study Start

May 1, 2013

Primary Completion

January 1, 2016

Study Completion

January 1, 2016

Last Updated

January 18, 2016

Record last verified: 2016-01

Locations